Boosting axitinib exposure with a CYP3A4 inhibitor, making axitinib treatment personal

Authors

  • Floor J. E. Lubberman Department of Pharmacy, Radboud University Medical Center, Nijmegen, The Netherlands
  • Nielka P. van Erp Department of Pharmacy, Radboud University Medical Center, Nijmegen, The Netherlands
  • Rob ter Heine Department of Pharmacy, Radboud University Medical Center, Nijmegen, The Netherlands
  • Carla M. L. van Herpen Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands

DOI:

https://doi.org/10.1080/0284186X.2017.1311024

Abstract

No Abstract Available

Downloads

Download data is not yet available.

Downloads

Published

2017-09-02

How to Cite

Lubberman, F. J. E. ., van Erp, N. P. ., Heine, R. ter ., & van Herpen, C. M. L. . (2017). Boosting axitinib exposure with a CYP3A4 inhibitor, making axitinib treatment personal. Acta Oncologica, 56(9), 1238–1240. https://doi.org/10.1080/0284186X.2017.1311024

Issue

Vol. 56 No. 9 (2017): Acta Oncologica

Section

Articles